The treatment of androgenetic alopecia (i.e.. of the cause for hair loss) with the help of stem cells, is still under clinical trials. More from 3.500 Stem cell clinical trials for various diseases are in place and involve patients whose problem has not responded to conventional therapies. Nonetheless, No center that makes applications for the treatment of alopecia can promise guaranteed results, as they differ from patient to patient.


The sure thing is stem cell therapy is autologous, i.e.. It is made with elements of the organism itself and is completely safe. also, stem cell therapy does not limit the possibilities for future hair transplantation. The hair follicles (hair) of the donor occipital region remain unaffected, so stem cell therapy may precede and delay a transplant.

In other cases, Stem cell therapy can be done years after the transplant in case the donor area is insufficient to give us new hair follicles, for repeat complementary transplantation.

The difficulties presented by stem cell therapy are:

  • Proper placement in the area of ​​thinning - as it is impossible to completely predetermine the direction in which the new hairs will grow
  • Determining the density of new hair growth

instead, during implantation-transplantation the doctor precisely determines the direction of the hair to be implanted and has control over the distribution of hair follicles at correct distances in the area.

By cloning the hair follicles through stem cell therapy it is not possible to accurately predict the percentage of hair follicles that will grow, nor to ensure uniform density.

Yet, no one can guarantee that the new hairs will follow the normal life cycle of the rest of the hairs in the area, nor that they will remain forever like the hairs we implant that come from the occipital region, which is not hormonally affected. We should also mention that, to approve hair follicle cloning in the future, it should be completely safe. This means that the stem cells must be cultured in specially accredited laboratories, which significantly increases the cost of treatment.

A review of clinical trials, shows us that at a research level the creation of new hairs from cells in the nipple of the hair follicle has been achieved (i.e.. of the hair root ) however in this, there is no clinical application yet. also, in the leading scientific journal "Nature" was published in January 2014 clinical study in which, from differentiated adult skin cells, epithelial stem cells were formed from which new hair follicles can emerge(!). Not in that either, there is clinical application to date.

One last post in February 2016, in the leading scientific journal "Science" entitled "Aging, alopecia and stem cells », refers to the investigation of the biochemical and genetic mechanism by which the cyclic activation and cessation of hair follicle stem cells takes place (Hair Folicle Stem Cells) during the regenerative phase (when i.e.. hair grows) and the telogen (i.e.. the resting phase of the hair) from protein agents such as Wnt (activation) and BMP (pause). Their research shows that alopecia is affected by both endogenous factors - such as the aging of the body's cells- but also by exogenous environmental factors.

in conclusion, Stem cell therapy can not yet replace hair transplantation which redistributes existing hair follicles without creating new ones, however it provides a guaranteed and permanent result. The scientific interest in stem cell therapies is promising., so that it is expected to give us in the near future applicable treatments with the creation of new hair follicles, which will be an unlimited source of new hair.

Please fill in the fields below, and we will answer any relevant question you have.